Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Autor: Felip, Enriqueta, de Braud, Filippo G., Maur, Michela, Loong, Herbert H., Shaw, Alice Tsang, Vansteenkiste, Johan F., John, Thomas, Liu, Geoffrey, Lolkema, Martijn P., Selvaggi, Giovanni, Giannone, Vanessa, Cazorla, Pilar, Baum, Jason, Balbin, O. Alejandro, Wang, Luojun (Victor), Lau, Yvonne Y., Scott, Jeffrey W., Tan, Daniel Shao-Weng
Zdroj: In Journal of Thoracic Oncology March 2020 15(3):392-403
Databáze: ScienceDirect